亚洲精品一区二区三区不卡,美国3级大鸡巴www.jb,二零二五a国产网站,日本中文高清视频一区

產(chǎn)品中心您現(xiàn)在的位置:首頁 > 產(chǎn)品展示 > 抗體 > 內(nèi)參抗體 > InVivoMab anti-human PD-1 (CD279)

InVivoMab anti-human PD-1 (CD279)

更新時間:2022-01-27

簡要描述:

The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of……

型號:廠商性質(zhì):代理商瀏覽量:961

The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1's structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.


產(chǎn)品名稱:InVivoMab anti-human PD-1 (CD279)

反應(yīng)種屬:human

宿主來源:mouse

實驗應(yīng)用:in vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice

同種型:IgG1, κ

克隆性:Monoclonal

克隆號:J116

產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml

保存溫度:Undiluted at 4°C in the dark

運輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

預(yù)期分子量:150 kDa

產(chǎn)品形式:液體

有效期:One year from the date of receipt if stored as recommended

產(chǎn)地:美國



如需購買或咨詢Bioxcell公司的產(chǎn)品,請聯(lián)系Bioxcell*代理商欣博盛生物


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯數(shù)字),如:三加四=7
欧美精品黑人的大鸡巴一区二区| 欧美日韩精品AAAA免费大片| 日韩五月婷婷| 亚洲三级片无码| 精品人妻视频在线观看| 欧美操B图| 石原莉奈在线播放一区二区三区| 日韩美女插逼| 91女主播在线观看| 频婷婷中文字幕| 操我视频啊啊| 操逼视频尻我逼骚| 91伊人在线| 在线欧美卡通视频| 五月婷婷六月香蕉免费在线观看亚洲综合| 久久人妻发布| 逼逼XXXX无码| 亚洲熟妇色yes| jooqichaopeng| 日韩欧美国产中文字幕 | 大几八和逼逼美女| 欧美情色一区| 哪个网站可以免费看三级片中文字幕| 99插逼视频| 极品白丝美女操逼网站| 韩日五十路老熟女| 百度好吊操这里只有精品| 狠狠99天堂| wwwxxx不卡一区| 日本二道在线视频| 溃疡性肠炎吃什么药最有疗效| 被大鸡巴操| 一本道大香蕉在线播放| 国产精品在线人体艺术| 亚洲天堂女优在线一区二区三区| 四川操B视频| 青青草原性爱视频在线播放| 日黑女人的b视频一区三区| 欧美美女在线操逼| 国产不卡二区视频| 大香蕉老司机一区二区|